Why this US growth stock is now my worst ever investment

Nearly every portfolio contains one or two flops. But I have one investment that is now down a whopping 80%. Should I sell it or keep on holding?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Middle-aged white man pulling an aggrieved face while looking at a screen

Image source: Getty Images

Like most investors, I’ve made a few mistakes over the years. I’m talking about the times I’ve bought a stock and it’s totally tanked. Well, after its 60% drop this year, Butterfly Network (NYSE: BFLY) stock is definitely a massive loser for me. In fact, it’s now my worst performing investment to date.

What’s gone wrong here?

SPAC mania

In 2020, there emerged a trend in the US where companies started going public via something called a ‘special purpose acquisition company‘ (SPAC). This is a company with a pile of money that it uses to buy or merge with another company in order to take it public.

Many of these companies were wildly overvalued a couple of years ago. And most of them have lost a substantial amount of their market value since. Butterfly Network went public through a SPAC in February 2021. That is around the time when I invested in the stock, at $19.

But rather than flying upwards, Butterfly Network stock has since had its wings brutally clipped. Today, less than two years later, the share price is $3.70. Its market cap has fallen from over $3bn to just $677m.

All in all, I’m nursing a painful 80% loss.

Unfulfilled promise

Butterfly Network is a health-tech company whose disruptive technology turns a smartphone into an ultrasound machine. Instead of traditional hardware, the company has pioneered a way to put ultrasound on a semiconductor chip.

The firm’s medical imaging devices are handheld and portable. And the mission is to make them as commonplace as stethoscopes for health professionals around the world.

Butterfly Network’s app allows clinicians to capture images, access patient information, and send scans. This software side of the business has much higher margins than the imaging hardware side.

The company reported revenue of $62.2m for the full year 2021, up 35% on 2020. However, prior to going public, Butterfly Network had originally guided for full-year 2022 revenue to be $138m. It has become obvious that the firm is going to fall well short of that target this year.

Meanwhile, it expects to lose between $145 million and $155 million for the full year. So basically, we’re looking at a company that overpromised but has so far under-delivered.

Stick or twist?

Peter Lynch once said: “In [investing], if you’re good, you’re right six times out of ten. But the times you’re right, it overcomes your mistakes”.

I was reminded of this quote today when I looked at my portfolio to check how much I’m actually down on this stock. That’s because directly above Butterfly Network (alphabetically) is my holding in Axon Enterprise. And that stock is up over nearly 300% for me, even after the overall stock market decline this year.

The gains from that one investment completely dwarf my losses in Butterfly Network shares. As Peter Lynch pointed out, the winners compensate for the losers, and then some.

Anyway, I’m not going to invest more money in Butterfly Network stock. The company has not grown as quickly as I’d hoped it would. And I overpaid for the stock, which I’m paying the price for now.

But I’m still not going to sell my shares just yet. Maybe they’ll take off one day and I’ll be happy I was patient.

Ben McPoland has positions in Axon Enterprise and Butterfly Network, Inc. The Motley Fool UK has recommended Axon Enterprise. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature black woman at home texting on her cell phone while sitting on the couch
Investing Articles

Down 32% and with a P/E of 9.5, is this FTSE 250 share too cheap to ignore?

This FTSE 250 share is in freefall after slashing guidance for this financial year. But Royston Wild eyes a potential…

Read more »

Chalkboard representation of risk versus reward on a pair of scales
Growth Shares

Why high oil prices could be good news for Lloyds shares

Jon Smith talks through the implications of elevated oil prices and translates that through to the potential impact on Lloyds'…

Read more »

Investing Articles

Lists of income stocks to buy almost never include this one — but with a forecast 8.2% yield, I think they should!

This FTSE firm, not always seen as an income play, has a forecast yield of 8.2%, underlining why it's one…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Aviva’s share price is down 13% to under £7, despite outstanding 2025 results! Time for me to buy more?

I think Aviva’s share price reflects an outdated view of the business, and that gap between perception and reality is…

Read more »

Arrow symbol glowing amid black arrow symbols on black background.
Investing Articles

Shell’s £33+ share price is near an all-time high, so why am I going to buy more as soon as possible?

Shell's strong cash generation and improving growth drivers contrast with a share price well below my valuation, suggesting major long‑term…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

An 8.4% forecast yield but down 16%! Time for me to buy more of this FTSE 100 passive income star?

This FTSE 100 passive‑income machine is delivering rising payouts and strong forecasts, and its share price suggests the market hasn’t…

Read more »

CEO Mark Zuckerberg at F8 2019 event
Investing Articles

£10,000 invested in Meta Platforms Stock 5 years ago is now worth…

Meta Platforms has been throwing good money after bad at Reality Labs since 2021, but the stock has more than…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£7,500 invested in Diageo shares 5 weeks ago is now worth…

Our writer wonders if Diageo shares are worth a look at a 14-year low, or whether this FTSE 100 spirits…

Read more »